FOLH1 and medical procedure: Among serum markers of prostate carcinogenesis, the detection of circulating tumour cells (CTCs) by RT-PCR for prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) mRNA proved to be positive in both peripheral blood and bone marrow (BM).